BridgeBio expects to become a cash-generation engine by 2028, projecting over $600,000,000 in profit from its four post-Phase 3 assets. Cash burn is projected to hold steady through 2026 as rising ...
Defiance isn’t about being difficult. It’s about being principled. It’s not about conflict. It’s about alignment. And when modeled well by those in positions of power, it has a ripple effect, making ...